Lataa...
Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries
PURPOSE: The high cost of oncology drugs threatens the affordability of cancer care. Previous research identified drivers of price growth of targeted oral anticancer medications (TOAMs) in private insurance plans and projected the impact of closing the coverage gap in Medicare Part D in 2020. This s...
Tallennettuna:
| Julkaisussa: | J Clin Oncol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Clinical Oncology
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5536165/ https://ncbi.nlm.nih.gov/pubmed/28471711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.72.3742 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|